Insider · CIK 0001612312

Bilenker Joshua H.

Reports to the SEC for 6 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001612312

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+90K sh	—	—	90,000
2025-06-05	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2024-06-06	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+54.3K sh	—	—	54,278
2024-06-06	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2023-06-08	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2022-06-09	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-06-06	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+65K sh	—	—	65,000
2021-06-09	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2021-02-03	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2021-02-03	SANASana Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,795
2021-02-03	SANASana Biotechnology, Inc.P Purchase	Director	PPurchase	+20K sh	$25.00	+$500K	20,000
2020-06-17	GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2019-06-10	GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−27.5K sh	$235.00	−$6.45M	0
2019-02-15	Loxo Oncology, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−163K sh	$235.00	−$38.2M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−319K sh	$235.00	−$74.9M	0
2019-02-15	Loxo Oncology, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−30K sh	$235.00	−$7.05M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−128K sh	$235.00	−$30.1M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−209K sh	$235.00	−$49.1M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−100K sh	$235.00	−$23.5M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−300K sh	$235.00	−$70.5M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−142K sh	$235.00	−$33.4M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−64.5K sh	$235.00	−$15.2M	0
2019-01-02	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+128K sh	—	—	128,000
2018-12-11	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−100 sh	$140.61	−$14.1K	164,407
2018-12-11	Loxo Oncology, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+10K sh	$13.67	+$137K	174,407
2018-12-11	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−1,200 sh	$140.15	−$168K	164,507
2018-12-11	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−3,393 sh	$136.79	−$464K	169,214
2018-12-11	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−1,153 sh	$135.76	−$157K	172,607
2018-12-11	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−647 sh	$134.63	−$87.1K	173,760
2018-12-11	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−2,407 sh	$137.63	−$331K	166,807
2018-12-11	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−1,100 sh	$139.05	−$153K	165,707
2018-12-11	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−10K sh	—	—	318,514
2018-12-10	Loxo Oncology, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+10K sh	$13.67	+$137K	174,407
2018-12-10	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−969 sh	$130.58	−$127K	173,438
2018-12-10	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−10K sh	—	—	328,514
2018-12-10	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−2,001 sh	$132.09	−$264K	171,437
2018-12-10	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−2,377 sh	$135.04	−$321K	164,907
2018-12-10	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−2,049 sh	$134.31	−$275K	167,284
2018-12-10	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−400 sh	$136.48	−$54.6K	164,507
2018-12-10	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−2,104 sh	$133.00	−$280K	169,333
2018-12-10	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−100 sh	$137.39	−$13.7K	164,407
2018-11-27	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−200 sh	$151.56	−$30.3K	164,407
2018-11-27	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−400 sh	$149.25	−$59.7K	164,607
2018-11-27	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−250 sh	$148.06	−$37K	165,007
2018-11-27	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−600 sh	$147.09	−$88.3K	165,257
2018-11-27	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−700 sh	$144.61	−$101K	165,857
2018-11-27	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−859 sh	$143.35	−$123K	166,557
2018-11-27	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−634 sh	$142.45	−$90.3K	167,416
2018-11-27	Loxo Oncology, Inc.S Sale	Director, President & CEO	SSale	−690 sh	$141.48	−$97.6K	168,050

Recent filings

Accepted (ET)
Jun 54
Bilenker Joshua H.0001612312-26-000002
SEC(opens sec.gov)
Jun 94
Bilenker Joshua H.0001562180-25-004646
SEC(opens sec.gov)
Jul 154/A
Bilenker Joshua H.0001562180-24-005715
SEC(opens sec.gov)
Jun 74
Bilenker Joshua H.0001562180-24-004838
SEC(opens sec.gov)
Jun 94
Bilenker Joshua H.0001562180-23-005030
SEC(opens sec.gov)
Feb 174
Bilenker Joshua H.0001562180-23-001518
SEC(opens sec.gov)
Jul 154
Bilenker Joshua H.0001728117-22-000071
SEC(opens sec.gov)
Jun 84
Bilenker Joshua H.0001562180-22-004945
SEC(opens sec.gov)
Jun 104
Bilenker Joshua H.0001728117-21-000068
SEC(opens sec.gov)
Feb 184/A
Bilenker Joshua H.0000899243-21-007194
SEC(opens sec.gov)
Feb 54
Bilenker Joshua H.0000899243-21-005076
SEC(opens sec.gov)
Jun 184
Bilenker Joshua H.0001209191-20-037635
SEC(opens sec.gov)
Jun 114
Bilenker Joshua H.0001209191-19-036209
SEC(opens sec.gov)
Feb 154
Bilenker Joshua H.0001567619-19-004566
SEC(opens sec.gov)

Companies

Address

C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 350

SEATTLE, WA, 98102